Solitary plasmacytoma: 10 years’ experience at All India Institute of Medical Sciences, New Delhi

Baghmar, Saphalta ; Mohanti, Bidhu K. ; Sharma, Atul ; Kumar, Lalit ; Prakash, Gaurav ; Kumar, Sanjeev ; Gupta, Ritu ; Kumar, Rajive ; Raina, Vinod (2013) Solitary plasmacytoma: 10 years’ experience at All India Institute of Medical Sciences, New Delhi Leukemia and Lymphoma, 54 (8). pp. 1665-1670. ISSN 1042-8194

Full text not available from this repository.

Official URL: http://www.tandfonline.com/doi/abs/10.3109/1042819...

Related URL: http://dx.doi.org/10.3109/10428194.2012.750725

Abstract

Plasma cell dyscrasias account for 1% of all malignancies and 10% of hematological malignancies. About 5% of patients with a plasma cell dyscrasia present with either solitary bone plasmacytoma (SBP) or, less commonly, a soft tissue mass, extramedullary plasmacytoma (EMP) of monoclonal plasma cells. In this study we present the clinical features, management and outcome of 60 patients with solitary plasmacytoma, who constituted 5.6% of 1129 patients with plasma cell dyscrasias treated over a 10-year period at All India Institute of Medical Sciences. Median age was 49 years. Fifty-two had SBP and eight had EMP. Forty-nine (82%) patients received radiotherapy with or without surgical excision or chemotherapy. Five-year event-free survival (EFS) and overall survival (OS) were 45.5% and 91%, respectively. Median EFS and OS were 38 and 122 months, respectively. Five-year survival rates in patients who developed multiple myeloma and those who did not were 81% and 100%, respectively. The median time of progression to myeloma was 21 months.

Item Type:Article
Source:Copyright of this article belongs to Taylor & Francis Group.
Keywords:Plasma Cell Dyscrasia; Plasmacytoma; Multiple Myeloma; India
ID Code:111123
Deposited On:25 Sep 2017 12:42
Last Modified:25 Sep 2017 12:42

Repository Staff Only: item control page